JPWO2023054292A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023054292A5 JPWO2023054292A5 JP2022565717A JP2022565717A JPWO2023054292A5 JP WO2023054292 A5 JPWO2023054292 A5 JP WO2023054292A5 JP 2022565717 A JP2022565717 A JP 2022565717A JP 2022565717 A JP2022565717 A JP 2022565717A JP WO2023054292 A5 JPWO2023054292 A5 JP WO2023054292A5
- Authority
- JP
- Japan
- Prior art keywords
- cov
- sars
- pharmaceutical composition
- composition according
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 241001678559 COVID-19 virus Species 0.000 claims 8
- 208000015181 infectious disease Diseases 0.000 claims 3
- 208000024891 symptom Diseases 0.000 claims 3
- 208000025721 COVID-19 Diseases 0.000 claims 2
- 208000001528 Coronaviridae Infections Diseases 0.000 claims 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 1
- 208000037847 SARS-CoV-2-infection Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000014599 transmission of virus Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021157929 | 2021-09-28 | ||
| JP2021157929 | 2021-09-28 | ||
| JP2021171725 | 2021-10-20 | ||
| JP2021171725 | 2021-10-20 | ||
| JP2022000723 | 2022-01-05 | ||
| JP2022000723 | 2022-01-05 | ||
| JP2022015035 | 2022-02-02 | ||
| JP2022015035 | 2022-02-02 | ||
| JP2022131590 | 2022-08-22 | ||
| JP2022131590 | 2022-08-22 | ||
| PCT/JP2022/035803 WO2023054292A1 (ja) | 2021-09-28 | 2022-09-27 | トリアジン誘導体を含有する医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP7236065B1 JP7236065B1 (ja) | 2023-03-09 |
| JPWO2023054292A1 JPWO2023054292A1 (https=) | 2023-04-06 |
| JPWO2023054292A5 true JPWO2023054292A5 (https=) | 2023-09-06 |
Family
ID=85476839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022565717A Active JP7236065B1 (ja) | 2021-09-28 | 2022-09-27 | トリアジン誘導体を含有する医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250127788A1 (https=) |
| EP (1) | EP4410292A4 (https=) |
| JP (1) | JP7236065B1 (https=) |
| KR (1) | KR20240082359A (https=) |
| CN (1) | CN119818502A (https=) |
| AU (1) | AU2022353486A1 (https=) |
| CA (1) | CA3233206A1 (https=) |
| MX (1) | MX2024003600A (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT4122926T (lt) * | 2021-04-14 | 2025-07-25 | Shionogi & Co., Ltd. | Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija |
| WO2023054732A2 (ja) * | 2022-01-19 | 2023-04-06 | 塩野義製薬株式会社 | 新型コロナウイルス感染症治療用医薬 |
| WO2024193451A1 (en) * | 2023-03-17 | 2024-09-26 | Ascletis BioScience Co., Ltd | Triazine derivatives, method of making and method of using thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999036410A1 (en) * | 1998-01-13 | 1999-07-22 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| PL2399910T3 (pl) | 2009-02-13 | 2014-09-30 | Shionogi & Co | Pochodne triazyny jako antagoniści receptora p2x3 i/albo p2x2/3 i kompozycja farmaceutyczna zawierająca je |
| CN103153968B (zh) | 2010-08-10 | 2016-02-03 | 盐野义制药株式会社 | 三唑衍生物及含有其的具有镇痛作用的药物组合物 |
| TW201331188A (zh) | 2011-12-15 | 2013-08-01 | Shionogi & Co | 經取代之三□衍生物及含有其之醫藥組成物 |
| TWI637949B (zh) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
| WO2019087884A1 (ja) * | 2017-10-31 | 2019-05-09 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| PH12021552872A1 (en) | 2020-04-05 | 2022-03-21 | Pfizer | Compounds and methods for the treatment of covid-19 |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| EP4282420A4 (en) * | 2021-01-20 | 2024-11-27 | National University Corporation Hokkaido University | ANTIVIRAL AGENT |
| EP4313097A4 (en) * | 2021-03-29 | 2025-03-19 | Shireen Nature Company for General Trading, Ltd. | Willow extract and its use in treating coronavirus infection, inflammation, and associated medical conditions |
| LT4122926T (lt) * | 2021-04-14 | 2025-07-25 | Shionogi & Co., Ltd. | Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija |
-
2022
- 2022-09-27 AU AU2022353486A patent/AU2022353486A1/en active Pending
- 2022-09-27 MX MX2024003600A patent/MX2024003600A/es unknown
- 2022-09-27 EP EP22876159.9A patent/EP4410292A4/en active Pending
- 2022-09-27 KR KR1020247013026A patent/KR20240082359A/ko active Pending
- 2022-09-27 JP JP2022565717A patent/JP7236065B1/ja active Active
- 2022-09-27 CA CA3233206A patent/CA3233206A1/en active Pending
- 2022-09-27 CN CN202510188695.9A patent/CN119818502A/zh active Pending
- 2022-09-27 US US18/696,097 patent/US20250127788A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023054292A5 (https=) | ||
| US11267801B2 (en) | Therapeutic compounds | |
| ES2670769T3 (es) | Derivados de (hetero)arilacetamida como agentes antirretrovirales | |
| JP2024516371A5 (https=) | ||
| JP2023166406A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| CN113906013A (zh) | 吡啶氮氧化合物及其制备方法和用途 | |
| JP2020507589A5 (https=) | ||
| JP2022505841A5 (https=) | ||
| JP2024541569A5 (https=) | ||
| JP2022505637A5 (https=) | ||
| JP2024544538A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| JPWO2023095860A5 (https=) | ||
| JP2021522255A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| JP5744003B2 (ja) | 抗ウイルス化合物を調製する方法 | |
| JP2019536778A5 (https=) | ||
| JP2020533402A5 (https=) | ||
| JPWO2025005306A5 (https=) | ||
| MX2022011392A (es) | Compuestos inhibidores de phd, composiciones y uso. | |
| JP2023518390A5 (https=) | ||
| EP2506854B1 (en) | Composition for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker | |
| EP4248960A3 (en) | Novel triterpene derivatives as hiv inhibitors | |
| JP2022529845A5 (https=) |